Michalis Hamilos
Overview
Explore the profile of Michalis Hamilos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Odanovic N, Tsioufis K, Dimitriadis K, Sakalidis A, Papafaklis M, Davlouros P, et al.
Cardiovasc Revasc Med
. 2024 Dec;
PMID: 39672766
Background: A considerable number of symptomatic patients leave the cardiac catheterization lab without a definitive diagnosis for their symptoms because no epicardial stenoses are found. The significance of disorders of...
2.
Tsigkas G, Toulgaridis F, Apostolos A, Kalogeropoulos A, Karamasis G, Vasilagkos G, et al.
Circ Cardiovasc Interv
. 2024 Sep;
17(9):e014045.
PMID: 39286899
Background: Coronary computed tomography angiography (CCTA) in patients with post-coronary artery bypass graft (CABG) has a high diagnostic accuracy for visualization of grafts. Invasive coronary angiography (ICA) in patients with...
3.
Kladou E, Kochiadakis G, Hamilos M
Heart
. 2024 Jun;
110(14):939-970.
PMID: 38918028
No abstract available.
4.
Skalidis I, Petousis S, Koliastasis L, Hamilos M, Skalidis E
JACC Cardiovasc Interv
. 2024 Apr;
17(8):1069.
PMID: 38658122
No abstract available.
5.
Anastasiou I, Patrianakos A, Vernardos M, Foukarakis E, Pitarokoilis M, Petousis S, et al.
Am Heart J Plus
. 2024 Apr;
23:100222.
PMID: 38560654
Introduction: Ticagrelor has been established as the P2Y-inhibitor of choice in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI); however, its use has not been adequately...
6.
Skalidis I, Kachrimanidis I, Koliastasis L, Arangalage D, Antiochos P, Maurizi N, et al.
Future Cardiol
. 2024 Jan;
19(16):755-758.
PMID: 38189213
Tweetable abstract Cardiology's digital revolution: AI diagnoses, ChatGPT consults, Metaverse educates. Challenges & promises explored. #CardiologyTech #DigitalHealth.
7.
Skalidis I, Hamilos M, Petousis S, Kochiadakis G, Skalidis E
Catheter Cardiovasc Interv
. 2023 Oct;
102(7):1386-1388.
PMID: 37855208
We present the first documented case of a successful closure of a transcatheter aortic valve replacement (TAVR)-induced Gerbode defect using a valve-in-valve approach. A 90-year-old female with severe aortic stenosis...
8.
Koliastasis L, Doundoulakis I, Rychter J, Zembala M, Ninios V, Ninios I, et al.
Hellenic J Cardiol
. 2023 Oct;
77:122-124.
PMID: 37778638
No abstract available.
9.
Skalidis I, Salihu A, Kachrimanidis I, Koliastasis L, Maurizi N, Dayer N, et al.
Can J Cardiol
. 2023 Sep;
39(11):1549-1552.
PMID: 37666480
No abstract available.
10.
Petousis S, Skalidis E, Zacharis E, Kochiadakis G, Hamilos M
J Clin Med
. 2023 Jul;
12(14).
PMID: 37510737
Interventional cardiologists in everyday practice are often confronted with calcified coronary lesions indicated for percutaneous transluminal coronary angioplasty (PTCA). PTCA of calcified lesions is associated with diverse technical challenges resulting...